An antifungal mechanism of curcumin lies in membrane-targeted action within Candida albicans

IUBMB Life

Volumn 66, Issue 11, 2014, Pages 780-785

  Lee, Wonyoung ^a   Lee, Dong Gun ^a  

^a Kyungpook National University   (South Korea)

Author keywords

antifungal effect; Candida albicans; curcumin; plasma membrane

Indexed keywords

1,6 DIPHENYL 1,3,5 HEXATRIENE; AMPHOTERICIN B; CURCUMIN; POTASSIUM ION; ANTIFUNGAL AGENT; BARBITURIC ACID DERIVATIVE; BIS(1,3-DIBUTYLBARBITURATE)TRIMETHINE OXONOL; CALCEIN; FLUORESCEIN DERIVATIVE; ISOXAZOLE DERIVATIVE; POTASSIUM; PROPIDIUM IODIDE;

ANTIFUNGAL ACTIVITY; ARTICLE; ARTIFICIAL MEMBRANE; CANDIDA ALBICANS; CELL MEMBRANE POTENTIAL; CONTROLLED STUDY; CYTOSOL; DRUG MECHANISM; DRUG TARGETING; FLUORESCENCE ANALYSIS; FUNGAL CELL; FUNGAL MEMBRANE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROPIDIUM IODIDE ASSAY; CELL MEMBRANE; DRUG EFFECTS; FLUORESCENCE; METABOLISM;

CANDIDA ALBICANS;

ANTIFUNGAL AGENTS; BARBITURATES; CANDIDA ALBICANS; CELL MEMBRANE; CURCUMIN; DIPHENYLHEXATRIENE; FLUORESCEINS; FLUORESCENCE; ISOXAZOLES; POTASSIUM; PROPIDIUM;

EID: 84920828978     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.1326     Document Type: Article

References (36)

1. Di Santo, R., (2010) Natural products as antifungal agents against clinically relevant pathogens. Nat. Prod. Rep. 27, 1084-1098.
2. Loeffler, J., and, Stevens, D. A., (2003) Antifungal drug resistance. Clin. Infect. Dis. 36, S31-S41.
3. Baddley, J. W., Winthrop, K. L., Patkar, N. M., Delzell, E., Beukelman, T., et al. (2011) Geographic distribution of endemic fungal infections among older persons, United States. Emerg. Infect. Dis. 17, 1664-1669.
4. Andes, D., Pascual, A., and, Marchetti, O., (2009) Antifungal therapeutic drug monitoring: established and emerging indications. Antimicrob. Agents Chemother. 53, 24-34.
5. Oelkrug, C., Lange, C. M., Wenzel, E., Fricke, S., Hartke, M., et al. (2014) Analysis of the tumoricidal and anti-cachectic potential of curcumin. Anticancer Res. 34, 4781-4788.
6. Kanai, M., (2014) Therapeutic applications of curcumin for patients with pancreatic cancer. World J. Gastroenterol. 20, 9384-9391.
7. Karewicz, A., Bielska, D., Gzyl-Malcher, B., Kepczynski, M., Lach, R., et al. (2011) Interaction of curcumin with lipid monolayers and liposomal bilayers. Colloids Surf. B Biointerfaces 88, 231-239.
8. Chen, G., Chen, Y., Yang, N., Zhu, X., Sun, L., et al. (2012) Interaction between curcumin and minetic biomembrane. Sci. China C Life Sci. 55, 527-532.
9. Hwang, I. S., Hwang, J. H., Choi, H., Kim, K. J., and, Lee, D. G., (2012) Synergistic effects between silver nanoparticles and antibiotics and the mechanisms involved. J. Med. Microbiol. 61, 1719-1726.
10. + leakage and inhibits respiration in Escherichia coli. Lett. Appl. Microbiol. 26, 355-358.
11. Park, C., Woo, E. R., and, Lee, D. G., (2009) Antifungal effect with apoptotic mechanism(s) of Styraxjaponoside C. Biochem. Biophys. Res. Commun. 390, 1256-1259.
12. Cho, J., Choi, H., Lee, J., Kim, M. S., Sohn, H. Y., et al. (2013) The antifungal activity and membrane-disruptive action of dioscin extracted from Dioscorea nipponica. Biochim. Biophys. Acta 1828, 1153-1158.
13. Park, S. C., Kim, M. H., Hossain, M. A., Shin, S. Y., Kim, Y., et al. (2008) Amphipathic α-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions. Biochim. Biophys. Acta 1778, 229-241.
14. Jung, H. J., Park, Y., Sung, W. S., Suh, B. K., Lee, J., et al. (2007) Fungicidal effect of pleurocidin by membrane-active mechanism and design of enantiomeric analogue for proteolytic resistance. Biochim. Biophys. Acta 1768, 1400-1405.
15. Makovitzki, A., Avrahami, D., and, Shai, Y., (2006) Ultrashort antibacterial and antifungal lipopeptides. Proc. Natl. Acad. Sci. USA 103, 15997-16002.
16. Angelova, M. I., and, Dimitrov, D. S., (1986) Liposome electroformation. Faraday Discuss. Chem. Soc. 81, 303-311.
17. Angelova, M. I., Sloeau, S., Meleard, P., Faucon, J. F., and, Bothorel, P., (1992) Preparation of giant vesicles by external AC electric fields. Kinetics and application. Prog. Colloid Polym. Sci. 89, 127-131.
18. Calderone, R. A., and, Fonzi, W. A., (2001) Virulence factors of Candida albicans. Trends Microbiol. 9, 327, 335.
19. Spampinato, C., and, Leonardi, D., (2013) Candida infections, causes, targets and resistance mechanisms: traditional and alternative antifungal agents. Biomed. Res. Int. 2013, 204-237.
20. Roosild, T. P., Castronovo, S., Healy, J., Miller, S., Pliotas, C., et al. (2010) Mechanism of ligand-gated potassium efflux in bacterial pathogens. Proc. Natl. Acad. Sci. USA 102, 19784-19789.
21. Peña, A., Sánchez, N. S., and, Calahorra, M., (2013) Effects of chitosan on Candida albicans: conditions for its antifungal activity. Biomed. Res. Int. 2013, 527-549.
22. Orlve, D. S., Nguyen, T., and, Lehrer, R. I., (2002) Potassium release, a useful tool for studying antimicrobial peptides. J. Microbiol. Methods 49, 325-328.
23. Lee, J., and, Lee, D. G., (2009) Antifungal properties of a peptide derived from the signal peptide of the HIV-1 regulatory protein, Rev. FEBS Lett. 583, 1544-1547.
24. Pina-Vaz, C., Sansonetty, F., and, Rodrigues, A. G., (2001) Cytometric approach for a rapid evaluation of susceptibility of Candida strains to antifungals. Clin. Microbiol. Infect. 7, 609-618.
25. Li, L., Shi, Y., Cheserek, M. J., Su, G., and, Le, G., (2013) Antibacterial activity and dual mechanisms of peptide analog derived from cell-penetrating peptide against Salmonella typhimurium and Streptococcus pyogenes. Appl. Microbiol. Biotechnol. 97, 1711-1723.
26. Filippov, A. V., Kotenkov, S. A., Munavirov, B., and, Antzutkin, O. N., (2014) Effect of curcumin on lateral diffusion of phosphatidylcholines in saturated and unsaturated bilayers. Langmuir 30, 10686-10690.
27. Peter, B. M., Shirtliff, M. E., and, Jabra-Rizk, M. A., (2010) Antimicrobial peptides: primeval molecules or future drugs? PLoS Pathog. 6, e1001067.
28. Kumar, A., Dhamgaye, S., Maurya, I. K., Singh, A., Sharma, M., et al. (2014) Curcumin targets cell wall integrity via calcineurin-mediated signaling in Candida albicans. Antimicrob. Agents Chemother. 58, 167-175.
29. Tamba, Y., Ariyama, H., Levadny, V., and, Yamazaki, M., (2010) Kinetic pathway of antimicrobial peptide magainin 2-induced pore formation in lipid membranes. J. Phys. Chem. B 114, 12018-12026.
30. Sharma, M., Dhamgaye, S., Singh, A., and, Prasad, R., (2012) Lipodome analysis reveals antifungal polyphenol curcumin affects membrane lipid homeostasis. Front. Biosci. (Elite Ed.) 4, 1195-1209.
31. Straume, M., and, Litman, B. J., (1987) Equilibrium and dynamic structure of large, unilamellar, unsaturated acyl chain phosphatidylcholine vesicles. Higher order analysis of 1,6-diphenyl-1,3,5-hexatriene and 1-[4-(trimetylammonio)phenyl]-6-phenyl-1,3,5-hexatriene anisotropy decay. Biochemistry 26, 5113-5120.
32. Brogden, K. A., (2005) Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 3, 238-250.
33. Wenzel, M., Kohl, B., Münch, D., Raatschen, N., Albada, H. B., et al. (2012) Proteomic response of Bacillus subtilis to lantibiotics reflects differences in interaction with the cytoplasmic membrane. Antimicrob. Agents Chemother. 56, 5749-5757.
34. Choi, H., Cho, J., Jin, Q., Woo, E. R., and, Lee, D. G., (2012) Antifungal property of dihydrodehydrodiconiferyl alcohol 9′-O-β- d -glucoside and its pore-forming action in plasma membrane of Candida albicans. Biochim. Biophys. Acta 1818, 1648-1655.
35. Wesolowska, O., Michalak, K., Maniewska, J., and, Hendrich, A. B., (2009) Giant unilamellar vesicles-a perfect tool to visualize phase separation and lipid rafts in model systems. Acta Biochim. Pol. 56, 33-39.
36. Tamba, Y., Tanaka, T., Yahagi, T., Yamashita, Y., and, Yamazaki, M., (2004) Stability of giant unilamellar vesicles and large unilamellar vesicles of liquid-ordered phase membranes in the presence of Triton X-100. Biochim. Biophys. Acta 1667, 1-6.